Deborah Crouch

Array ( [id] => 3774756 [patent_doc_number] => 05850004 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Transgenic mouse deficient in inducible nitric oxide synthase' [patent_app_type] => 1 [patent_app_number] => 8/808191 [patent_app_country] => US [patent_app_date] => 1997-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 12710 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/850/05850004.pdf [firstpage_image] =>[orig_patent_app_number] => 808191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4153402 [patent_doc_number] => 06103523 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Pluripotent rabbit cell lines and method of making' [patent_app_type] => 1 [patent_app_number] => 8/810945 [patent_app_country] => US [patent_app_date] => 1997-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 4348 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103523.pdf [firstpage_image] =>[orig_patent_app_number] => 810945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4307996 [patent_doc_number] => 06252133 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Unactivated oocytes as cytoplast recipients of quiescent and non-quiescent cell nuclei, while maintaining correct ploidy' [patent_app_type] => 1 [patent_app_number] => 8/803165 [patent_app_country] => US [patent_app_date] => 1997-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6764 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/252/06252133.pdf [firstpage_image] =>[orig_patent_app_number] => 803165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4136014 [patent_doc_number] => 06147276 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Quiescent cell populations for nuclear transfer in the production of non-human mammals and non-human mammalian embryos' [patent_app_type] => 1 [patent_app_number] => 8/802282 [patent_app_country] => US [patent_app_date] => 1997-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8897 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/147/06147276.pdf [firstpage_image] =>[orig_patent_app_number] => 802282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4386383 [patent_doc_number] => 06278040 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Receptor-deficient mice and cell lines derived therefrom, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/802468 [patent_app_country] => US [patent_app_date] => 1997-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8088 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/278/06278040.pdf [firstpage_image] =>[orig_patent_app_number] => 802468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4302737 [patent_doc_number] => 06326198 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells' [patent_app_type] => 1 [patent_app_number] => 8/797730 [patent_app_country] => US [patent_app_date] => 1997-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12405 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326198.pdf [firstpage_image] =>[orig_patent_app_number] => 797730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935410 [patent_doc_number] => 20020061293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'TRANSDUCED HUMAN HEMATOPOIETIC STEM CELLS' [patent_app_type] => new [patent_app_number] => 08/796043 [patent_app_country] => US [patent_app_date] => 1997-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5606 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061293.pdf [firstpage_image] =>[orig_patent_app_number] => 08796043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177374 [patent_doc_number] => 06149904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Method for inhibiting tumor cell growth by administering to tumor cells expressing a nucleic acid encoding a connexin and a pro-drug' [patent_app_type] => 1 [patent_app_number] => 8/791291 [patent_app_country] => US [patent_app_date] => 1997-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13685 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/149/06149904.pdf [firstpage_image] =>[orig_patent_app_number] => 791291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998244 [patent_doc_number] => 06004550 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Intracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug system' [patent_app_type] => 1 [patent_app_number] => 8/776246 [patent_app_country] => US [patent_app_date] => 1997-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 11425 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004550.pdf [firstpage_image] =>[orig_patent_app_number] => 776246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3774740 [patent_doc_number] => 05850003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Transgenic rodents harboring APP allele having swedish mutation' [patent_app_type] => 1 [patent_app_number] => 8/785943 [patent_app_country] => US [patent_app_date] => 1997-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 15765 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/850/05850003.pdf [firstpage_image] =>[orig_patent_app_number] => 785943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4053189 [patent_doc_number] => 05969210 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Methods for the characterization of compounds which stimulate STF-1 expression in pancreatic islet cells' [patent_app_type] => 1 [patent_app_number] => 8/786527 [patent_app_country] => US [patent_app_date] => 1997-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 26 [patent_no_of_words] => 12042 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/969/05969210.pdf [firstpage_image] =>[orig_patent_app_number] => 786527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1286752 [patent_doc_number] => 06632427 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Adenoviral-vector-mediated gene transfer into medullary motor neurons' [patent_app_type] => B1 [patent_app_number] => 08/785074 [patent_app_country] => US [patent_app_date] => 1997-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 11727 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632427.pdf [firstpage_image] =>[orig_patent_app_number] => 08785074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4007747 [patent_doc_number] => 05962313 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme' [patent_app_type] => 1 [patent_app_number] => 8/784757 [patent_app_country] => US [patent_app_date] => 1997-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 16345 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962313.pdf [firstpage_image] =>[orig_patent_app_number] => 784757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3779634 [patent_doc_number] => 05817912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Transgenic mice with disrupted NPY Y1 receptor genes' [patent_app_type] => 1 [patent_app_number] => 8/784289 [patent_app_country] => US [patent_app_date] => 1997-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 10686 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817912.pdf [firstpage_image] =>[orig_patent_app_number] => 784289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831461 [patent_doc_number] => 05846528 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence' [patent_app_type] => 1 [patent_app_number] => 8/785750 [patent_app_country] => US [patent_app_date] => 1997-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17047 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846528.pdf [firstpage_image] =>[orig_patent_app_number] => 785750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3927295 [patent_doc_number] => 05945577 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Cloning using donor nuclei from proliferating somatic cells' [patent_app_type] => 1 [patent_app_number] => 8/781752 [patent_app_country] => US [patent_app_date] => 1997-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9884 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945577.pdf [firstpage_image] =>[orig_patent_app_number] => 781752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1393144 [patent_doc_number] => 06548735 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Production of heterologous protein in milk of transgenic non-human mammals comprising a construct with an intron' [patent_app_type] => B1 [patent_app_number] => 08/781518 [patent_app_country] => US [patent_app_date] => 1997-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 31 [patent_no_of_words] => 16784 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548735.pdf [firstpage_image] =>[orig_patent_app_number] => 08781518 [rel_patent_id] =>[rel_patent_doc_number] =>)